Whereas E-cadherin acts as a tumour suppressor in most epithelial tissues, P-cadherin de novo expression or upregulation has been linked to mammary cells’ proliferation and migration in mice [6], tumour-promotion in gastric [7,8] and breast cancer [9,10], and worse prognosis in breast cancer [11,12,13]. This evidence concerns the gene CDH3 and breast cancer.